E-MAIL   PASSWORD Forgot password?New user?
Diabetes and Endocrinology

Multiple complaints in a tired woman with vaginal bleeding

Barbara A. Majeroni, MD

 

The nurse’s note read “IUD removal—bleeding,” so I was surprised as I entered the room to see a woman who appeared 20 years older than the 36 years noted on the chart. Since Mrs V was a new patient, I took some history. She spoke slowly and seemed tired and uninterested. In good health until recently, she had not seen a doctor since her postpartum visit after the birth of her 11-year-old son. That was when her intrauterine device (IUD) was inserted.

    The Structured Testing Program (STeP) Study

    Medical Crossfire Primary Care, Apr 2011

    Multiple complaints in a tired woman with vaginal bleeding

    Medical Crossfire Women's Health, Jun 2009

    Growth Hormone Replacement for Adults: An Overview

    Medical Crossfire Diabetes and Endocrinology, Feb 2009

     
    Page 1 2 
    • The Structured Testing Program (STeP) Study

      Doctors:Dr. Steven EdelmanProfessor of Medicine at the University of California, San Diego Dr. Pamela Kushner Clinical Professo...

      The history holds the key in this gardener with a skin infection

      The patient is a 75-year-old retired white male with a 3-day history of ...

    • Growth Hormone Replacement for Adults: An Overview

      Physician and patient interest in growth hormone replacement therapy for adults is increasing. To provide a general and brief overview of the key issues related to human growth hormone, we arrived at group consensus on the topics that needed to be ad...

      Looking beyond hypertension: impact of RAS blockade in patients with type 2 diabetes and minority populations

      African American, Hispanic, South Asian, and Pima Indian populations are at high risk for cardiovascular mortality and morbidity, partly owing to greater prevalence of diabetes and obesity. Angiotensin-converting enzyme inhibitors and angiotensin rec...

    • From HOPE to TRANSCEND: a continuing profile of cardiovascular protection

      The original Heart Outcomes Prevention Evaluation study (HOPE) demonstrated that the angiotensin-converting enzyme (ACE) inhibitor, ramipril, reduced the 3-part composite end point of cardiovascular death, myocardial infarction, and stroke by 22% in ...

      Target organ protection in patients with cardiovascular disease: beyond blood pressure control

      Primary care clinicians are ideally situated to help reduce morbidity and mortality associated with vital organ damage in patients with hypertension. Relationships between elevated blood pressure (BP)—particularly systolic BP—and outcomes are well es...